Physician

Monica Mechele Colvin, M.D.

According to 2025 Medicare claims, Monica Colvin, M.D. (NPI: 1457388431) practices advanced heart failure and transplant cardiology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF MICHIGAN (NPI: 1891205969; TIN: 386006309) and primary practice location at 48109-5000. Colvin is affiliated with the POM ACO (ACO ID: A1297), McLaren High Performance Network, LLC (ACO ID: A3317), and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Colvin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 77 traditional Medicare patients, billed 291 HCPCS/CPT codes, and received $26,128 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,495 prescription claims across 124 beneficiaries totaling $708,755 in drug costs, led by Vyndamax (Tafamidis). DME data shows 42 claims. Open Payments data shows 1 records totaling $142. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $49,768 to $26,128. In contrast, Part D prescription costs have risen steadily, from $128,550 to $708,755. For DME billing, this smaller-volume category fell sharply in recent years, from $21,574 to $3,533.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	334	868	$49,768
2016	396	893	$57,348
2017	178	602	$42,657
2018	179	602	$44,534
2019	182	695	$51,365
2020	179	718	$53,093
2021	127	458	$33,062
2022	107	397	$32,759
2023	90	321	$28,530
2024	77	291	$26,128

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	144	911	$128,550
2016	134	979	$62,827
2017	158	1,356	$130,444
2018	166	1,752	$192,895
2019	184	2,095	$352,551
2020	170	2,099	$646,530
2021	163	1,964	$850,910
2022	136	1,772	$799,779
2023	136	1,696	$774,785
2024	124	1,495	$708,755

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	76	351	$34,841
2016	N/R	65	$4,461
2017	N/R	118	$30,706
2018	N/R	42	$4,790
2019	N/R	26	$27,887
2020	N/R	31	$2,328
2021	N/R	11	$302
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	42	$4,584

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	28	37	$139
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	24	30	$101
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	35	146	$94
99239	Hospital discharge day management, more than 30 minutes	14	17	$91
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	15	15	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	14	420	$304,125
Entresto	Sacubitril/Valsartan	158	9,267	$199,579
Jardiance	Empagliflozin	60	4,047	$76,237
Farxiga	Dapagliflozin Propanediol	34	2,212	$40,677
Eliquis	Apixaban	14	1,020	$18,420

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	15	$2,499
J2260	Injection, milrinone lactate, 5 mg	N	N/R	13	$1,556
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	14	$529

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$142	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Monica Mechele Colvin, M.D.?

Tedicare shows public-source Medicare data for Monica Mechele Colvin, M.D. (NPI 1457388431), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Monica Mechele Colvin, M.D. have ACO affiliation data?

Monica Mechele Colvin, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), McLaren High Performance Network, LLC (MSSP, ACO ID A3317), and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Monica Mechele Colvin, M.D.?

Monica Mechele Colvin, M.D. is linked to REGENTS OF THE UNIVERSITY OF MICHIGAN (billing NPI 1891205969) in the available physician profile data.

Does Monica Mechele Colvin, M.D. have Open Payments data?

Monica Mechele Colvin, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.